MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/microorganisms9071543

Медицинская библиотека · Microorganisms · 2021

A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.

Van Daele Ruth, Bekkers Britt, Lindfors Mattias, Broman Lars Mikael, Schauwvlieghe Alexander, Rijnders Bart, Hunfeld Nicole G M, Juffermans Nicole P, Taccone Fabio Silvio, Coimbra Sousa Carlos Antônio, Jacquet Luc-Marie, Laterre Pierre-François, Nulens Eric, Grootaert Veerle, Lyster Haifa, Reed Anna, Patel Brijesh, Meersseman Philippe, Debaveye Yves, Wauters Joost, Vandenbriele Christophe, Spriet Isabel

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Voriconazole is one of the first-line therapies for invasive pulmonary aspergillosis. Drug concentrations might be significantly influenced by the use of extracorporeal membrane oxygenation (ECMO). We aimed to assess the effect of ECMO on voriconazole exposure in a large patient population.

METHODS

Critically ill patients from eight centers in four countries treated with voriconazole during ECMO support were included in this retrospective study. Voriconazole concentrations were collected in a period on ECMO and before/after ECMO treatment. Multivariate analyses were performed to evaluate the effect of ECMO on voriconazole exposure and to assess the impact of possible saturation of the circuit's binding sites over time.

RESULTS

Sixty-nine patients and 337 samples (190 during and 147 before/after ECMO) were analyzed. Subtherapeutic concentrations (<2 mg/L) were observed in 56% of the samples during ECMO and 39% without ECMO (p = 0.80). The median trough concentration, for a similar daily dose, was 2.4 (1.2-4.7) mg/L under ECMO and 2.5 (1.4-3.9) mg/L without ECMO (p = 0.58). Extensive inter-and intrasubject variability were observed. Neither ECMO nor squared day of ECMO (saturation) were retained as significant covariates on voriconazole exposure.

CONCLUSIONS

No significant ECMO-effect was observed on voriconazole exposure. A large proportion of patients had voriconazole subtherapeutic concentrations.

Для цитирования: Van Daele Ruth, Bekkers Britt, Lindfors Mattias, Broman Lars Mikael, Schauwvlieghe Alexander, Rijnders Bart, Hunfeld Nicole G M, Juffermans Nicole P, Taccone Fabio Silvio, Coimbra Sousa Carlos Antônio, Jacquet Luc-Marie, Laterre Pierre-François, Nulens Eric, Grootaert Veerle, Lyster Haifa, Reed Anna, Patel Brijesh, Meersseman Philippe, Debaveye Yves, Wauters Joost, Vandenbriele Christophe, Spriet Isabel. A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.. Microorganisms. 2021. DOI: 10.3390/microorganisms9071543.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.